Navigation Links
Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
Date:5/20/2008

ing Statements

Certain of the statements contained in this news release are forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks are: the impact of general economic conditions, general conditions in the biotech industry, changes in the regulatory environment in the jurisdictions in which Haemacure does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. Haemacure disclaims any intention or obligation to update these statements.


'/>"/>
SOURCE Haemacure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
3. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
4. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
5. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
6. Haemacure Reports on its annual general and special meeting of shareholders
7. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
8. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
9. Haemacure financing receives shareholder consent - Series B Warrants are amended
10. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , SAN FRANCISCO, Dec. 4 Me...as the favorite dispensary in the SF Bay Area by p...weedmaps.com. Despite only three months in operat...as the preeminent location for accessing medicinal...of Medithrive confirms the obvious: a dispensary w...
(Date:12/4/2009)... , MADISON HEIGHTS, Mich., Dec. 4 /...es Review Committee of BetterInvesting Magazine ... its February 2010 "Stock to Study" and C.R. Bard...valued Stock" for investors, informational and edu...because of growth opportunities involving its flag...
(Date:12/4/2009)... , STANFORD, Calif. A new study shows that mu...ne,s ability to squeeze shut properly. The work, p...reat patients with conditions such as gastric refl...be used to strengthen sphincters, which are the ba...your intestinal tract. Weakness in these areas can...
(Date:12/4/2009)... Dental tourism is a phenome...or an alternative to the high price of dental work...search for lower priced dental care, people have f...e as a dental tourist destination. , ...g in business for more than 6 years, Mexican Denta...
(Date:12/4/2009)... , Dr. Redlener Applauds Historic Effor...y Net Programs Are Lost in Final Health Care Refor... -- The New England Journal of Medicine today ...ealth care reform, co-authored by Irwin Redlener, ...or, National Center for Disaster Preparedness and ...
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2
...d and Drug Administration have lifted a 14 year ba...s. //Allergan Inc of Irvine and Mentor Corporation... to market the implants to women over 22 years of ... of clinical data to garner support for marketing ...
...ts treated with Actonel are more likely to sustain...e published today in the peer-reviewed journal Ost... 33,000 women with osteoporosis. The study of ...(risedronate sodium) were approximately half as li...
..., announced on Thursday that he proposed to intro...laces. // The bill is better known as "Texas... restaurants and other public places would be bann... "Even though cities all over the state - includin...
... one thing – in this case, increase the heart rate... time you get a sudden jolt, adrenaline (a.k.a. ep...r. Nevin A. Lambert, a biophysicist at the Medical...ch, to be published in the Nov. 21 print issue of ...
... are affected by Obstructive Sleep Apnea (OSA) and... harmful //psychological symptoms than people with...in Journal of Forensic Sciences. Sex offender... mouth through a respiratory mask while the subjec...
...(MBL) of the University of Massachusetts Medical S...y announce //the formation of an historic collabor...tive approach for preventing rabies in people. ...U.S. Centers for Disease Control and Prevention (C...
Other Medicine News:Health News:FDA gives the green signal for silicone breast implants 2Health News:Actonel Treats Hip Fractures In A Better Way Than Alendronate 2Health News:Sticky Proteins Provide New Insight Into Drug Action 2Health News:Sticky Proteins Provide New Insight Into Drug Action 3Health News:International Collaboration Takes Aim at Rabies 2Health News:International Collaboration Takes Aim at Rabies 3
(Date:12/4/2009)...SALT LAKE CITY, Dec. 4 D...it has signed a sole-source vendor agreement to pr...hmark Physical Therapy with 65 clinics located in ...e named the sole-source supplier to Benchmark Phys...ice president of sales and marketing at Dynatronic...
(Date:12/4/2009)..., , LAKE FOREST, Ill., Dec. 4 /PRNewswi...eading global specialty pharmaceutical and medicat...f its next-generation 50 mL and 100 mL VisIV(TM) c...olutions, and now offers a complete size range (50...responsible VisIV product. The launch of the 50 mL...
(Date:12/4/2009)..., BILLERICA, Mass., Dec. 4 /PRNewswire-FirstCall...idiary of Volcano Corporation (Nasdaq: VOLC ), to...ul testing of a novel integrated light source arch...prietary optical engine design raises the bar on i... of laser-based designs for swept source OCT light...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 1Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 2Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 3Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 4Unique Facility Designed for the Comfort of Hospice Patients and Their Families 49585 1Unique Facility Designed for the Comfort of Hospice Patients and Their Families 49585 2Unique Facility Designed for the Comfort of Hospice Patients and Their Families 49585 3BioMed Realty Trust Closes New 2418 Million Secured Loan 49580 1BioMed Realty Trust Closes New 2418 Million Secured Loan 49580 2BioMed Realty Trust Closes New 2418 Million Secured Loan 49580 3
...ASHVILLE, Tenn., Feb. 25 After all standard treat...ed the growth of aggressive sarcomas in two recent...otocol,s previous success against several cancers,...ma and other sarcomas. , , One of the patients is...a (MFH) that arose in the largest bone of his leg....
...rimate trials validate efficacy of the process , ...Inc. announced today that it has successfully comp...ficacy of the proprietary bone growth regeneration... 100% fusion was obtained in a 3 month period. No...ntly preparing Pre-IDE studies. , , Bone Biologic...
Other Medicine Technology:New Cancer Treatment Stops Aggressive Sarcomas 2Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix 2
SterilGARDIII Advance; SG-603
ANALYTICAL BALANCES AW320
A&D HM-300
A&D GR-200
Medicine Products: